Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 5, 2005, Pages 368-372

  Montalcini, Tiziana ^a   Gorgone, Gaetano ^a   Federico, Domenico ^b   Ceravolo, Roberto ^a   Emanuele, Vittorio ^a   Sesti, Giorgio ^a   Perticone, Francesco ^a   Pujia, Arturo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Unit of Internal Medicine   (Italy)

Author keywords

Atherosclerosis; Carotid; LDL cholesterol; Menopausal women; Metabolic syndrome

Indexed keywords

EID: 27644514574     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2004.10.003     Document Type: Article

References (19)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular mortality in middle aged men. JAMA 2002;288:2709-16.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
5. Ridker PM, Buring JA, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-7.
6. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, for the Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.
7. Lernfelt B, Forsberg M, Blomstrand C, Mellstrom D, Volkmann R. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke 2002;33:224-9.
8. Joakimsen O, Bonaa KH, Mathiesen EB, Stensland-Bugge E, Arnesen E. Prediction of mortality by ultrasound screening of a general population for carotid stenosis: the Tromso Study. Stroke 2000;31:1871-6.
9. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL. Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 1994;17:1330-6.
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
11. Gordon T, Kannel WB, Castelli WP, Dauber TR. Lipoproteins, cardiovascular disease, and death: the Framingham Study. Arch Intern Med 1981;141:1128-31.
12. Austin MA, Mykkanen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM, et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995;92:1770-8.
13. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease: Paris prospective study. Diabetes Care 1991;14:461-9.
14. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL the Strong Heart Study. Arterioscler Thromb Vasc Biol 2000;20:830-5.
15. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316(7134):823-8.
16. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002;51:3069-76.
17. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-6.
18. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, et al. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2243-7.
19. Fagerberg B, Bokemark L, Hulthe J. The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men. Nutr Metab Cardiovasc Dis 2001;11:227-35.